Cambridge Investment Research Advisors, Inc. Tekla Life Sciences Investors Transaction History
Cambridge Investment Research Advisors, Inc.
- $26 Billion
- Q1 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 10,927 shares of HQL stock, worth $145,547. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,927
Previous 10,426
4.81%
Holding current value
$145,547
Previous $140,000
6.43%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding HQL
# of Institutions
80Shares Held
8.52MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY2.46MShares$32.8 Million0.58% of portfolio
-
Morgan Stanley New York, NY484KShares$6.45 Million0.0% of portfolio
-
1607 Capital Partners, LLC Richmond, VA481KShares$6.41 Million0.54% of portfolio
-
Allspring Global Investments Holdings, LLC431KShares$5.75 Million0.01% of portfolio
-
Aqr Arbitrage LLC Greenwich, CT387KShares$5.16 Million0.32% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...